Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 62,774 shares at $104.59 ($6.6M) on 2026-08-31, disclosed to the SEC on 2026-09-01.
Scheduled sale ($6.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.59 | 23,072 | $2.4M | 36.5% |
| 2 | $105.37 | 11,514 | $1.2M | 18.3% |
| 3 | $106.20 | 28,188 | $3.0M | 45.2% |
| Total | $105.46 avg | 62,774 | $6.6M | 100% |
| Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |
| RYTM | SELL | 2025-07-11 | $4.8M | — | Filing → |